Ignite Creation Date:
2025-12-25 @ 2:53 AM
Ignite Modification Date:
2026-01-09 @ 2:57 PM
Study NCT ID:
NCT02146833
Status:
TERMINATED
Last Update Posted:
2023-01-26
First Post:
2014-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SHIP (Selinexor in Hormone Insensitive Prostate Cancer)
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
None
Primary Completion Date:
2016-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-13
First Submit QC Date:
None
Study First Post Date:
2014-05-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-12-03
Results First Submit QC Date:
None
Results First Post Date:
2021-01-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-24
Last Update Post Date:
2023-01-26
Last Update Post Date Type:
ACTUAL